71 related articles for article (PubMed ID: 8869042)
1. [A study of the expression of MDR1 gene in solid tumors. Initial results of a multicenter evaluation].
Chevillard S; Vielh P; Vallidire P; Robert J; Marie JP
Bull Cancer; 1996 Aug; 83(8):626-33. PubMed ID: 8869042
[TBL] [Abstract][Full Text] [Related]
2. French multicentric evaluation of mdr1 gene expression by RT-PCR in leukemia and solid tumours. Standardization of RT-PCR and preliminary comparisons between RT-PCR and immunohistochemistry in solid tumours. French Network of the Drug Resistance Intergroup, and Drug Resistance Network of Assistance Publique-Hôpitaux de Paris.
Chevillard S; Vielh P; Validire P; Marie JP; Faussat AM; Barbu V; Bayle C; Bénard J; Bonnal C; Boutonnat J; Calvo F; Charrier J; Clary A; Colosetti P; Danel-Moore L; Decrémoux P; Delvincourt C; Finat-Duclos F; Genne P; Kataki A; Kouyoumdjian JC; Lacave R; Maugard C; Merlin JL; Robert J
Leukemia; 1997 Jul; 11(7):1095-106. PubMed ID: 9204997
[TBL] [Abstract][Full Text] [Related]
3. Association of mdr1 gene expression with other prognostic factors and clinical outcome in human breast cancer.
Punyammalee B; Manoromana S; Purisa W; Chariyalertsak S; Rerkamnuaychok B
J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S162-73. PubMed ID: 9347665
[TBL] [Abstract][Full Text] [Related]
4. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N
Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
[TBL] [Abstract][Full Text] [Related]
5. MDR1 gene expression in primary and advanced breast cancer.
Yang X; Uziely B; Groshen S; Lukas J; Israel V; Russell C; Dunnington G; Formenti S; Muggia F; Press MF
Lab Invest; 1999 Mar; 79(3):271-80. PubMed ID: 10092063
[TBL] [Abstract][Full Text] [Related]
6. [Multicentric evaluation of MDR phenotype in leukemia: intermediate analysis of the French study].
Perrot JY; Faussat AM; Zhou DC; Zittoun R; Robert J; Marie JP
Bull Cancer; 1996 Aug; 83(8):634-40. PubMed ID: 8869043
[TBL] [Abstract][Full Text] [Related]
7. [Reversal of multi-drug resistance in ovarian cancer cell by RNA interference].
Lou JY; Peng ZL; Zheng Y; Wang H; He B; Wang HJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):413-6. PubMed ID: 16831368
[TBL] [Abstract][Full Text] [Related]
8. Immunomagnetic purification of human breast carcinoma cells allows tumor-specific detection of multidrug resistance gene 1-mRNA by reverse transcriptase polymerase chain reaction in fine-needle aspirates.
Maas RA; Bruning PF; Breedijk AJ; Top B; Peterse HL
Lab Invest; 1995 Jun; 72(6):760-4. PubMed ID: 7540237
[TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance gene (MDR1) expression in human brain tumors.
Nabors MW; Griffin CA; Zehnbauer BA; Hruban RH; Phillips PC; Grossman SA; Brem H; Colvin OM
J Neurosurg; 1991 Dec; 75(6):941-6. PubMed ID: 1682428
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of gene MDR1 by shRNA to reverse multidrug-resistance of ovarian cancer A2780 cells.
Zhang H; Wang J; Cai K; Jiang L; Zhou D; Yang C; Chen J; Chen D; Dou J
J Cancer Res Ther; 2012; 8(2):226-31. PubMed ID: 22842366
[TBL] [Abstract][Full Text] [Related]
11. RNA expression of MDR1/P-glycoprotein, DNA-topoisomerase I, and MRP2 in ovarian carcinoma patients: correlation with chemotherapeutic response.
Materna V; Pleger J; Hoffmann U; Lage H
Gynecol Oncol; 2004 Jul; 94(1):152-60. PubMed ID: 15262134
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients.
Vaclavikova R; Nordgard SH; Alnaes GI; Hubackova M; Kubala E; Kodet R; Mrhalova M; Novotny J; Gut I; Kristensen VN; Soucek P
Pharmacogenet Genomics; 2008 Mar; 18(3):263-73. PubMed ID: 18300948
[TBL] [Abstract][Full Text] [Related]
13. [Mechanisms of multidrug resistance in tumor cells and analytical methods for its detection].
Takemura Y; Kobayashi H; Miyachi H
Rinsho Byori; 1998 Aug; 46(8):745-58. PubMed ID: 9760826
[TBL] [Abstract][Full Text] [Related]
14. [Reversal of nomegestrol acetate on multidrug resistance in drug-resistant human breast cancer cell line MCF7/ADR].
Li J; Xu L; He K; Guo W; Zhu X; Zheng Y; Xia P
Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):129-32. PubMed ID: 12015032
[TBL] [Abstract][Full Text] [Related]
15. [Clinical correlations of multidrug resistance gene expression in ovarian carcinoma].
Chen X; Li L; Huang W
Zhonghua Fu Chan Ke Za Zhi; 1996 Nov; 31(11):652-5. PubMed ID: 9387523
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of ovarian cancer chemotherapy by delivery of multidrug-resistance gene small interfering RNA using tumor targeting Salmonella.
Deng J; Guo Y; Jiang Z; Yang M; Li H; Wang J
J Obstet Gynaecol Res; 2015 Apr; 41(4):615-22. PubMed ID: 25370788
[TBL] [Abstract][Full Text] [Related]
17. Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells.
Tsang WP; Kwok TT
Oncogene; 2007 Jul; 26(33):4877-81. PubMed ID: 17297456
[TBL] [Abstract][Full Text] [Related]
18. [Experimental study of adenovirus-mediated p53 gene on the reversal of multidrug resistance in breast cancer].
He SZ; Qi XD; Zhang XM; Wang Y
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2935-7. PubMed ID: 18261311
[TBL] [Abstract][Full Text] [Related]
19. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: relationship to MDR1, MnSOD, and TNF gene expression.
Zyad A; Bénard J; Tursz T; Clarke R; Chouaib S
Cancer Res; 1994 Feb; 54(3):825-31. PubMed ID: 7905787
[TBL] [Abstract][Full Text] [Related]
20. [Expression of microRNA 27a and its correlation with drug resistance in human ovarian cancer A2780/Taxol cells].
Li ZM; Hu S; Xiao L; Wang J; Cai J; Yu LL; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2010 May; 45(5):372-5. PubMed ID: 20646448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
